首页 › 基金 › Invenomic Capital Management LP › GEHC
Invenomic Capital Management LP 对 GEHC 的持仓历史
GE HEALTHCARE TECHNOLOGIES I · 医疗保健
Invenomic Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 GEHC(GE HEALTHCARE TECHNOLOGIES I)579,705 股,市值约 US$37.9M,约占其申报组合的 1.87%,在其申报持仓中市值排名第 14 位。 Invenomic Capital Management LP 最近 6 个申报季度中有 3 个季度披露了 GEHC 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Invenomic Capital Management LP 对 GEHC 的持仓演变
Invenomic Capital Management LP 于 Q2 2025 首次披露 GEHC 持仓:96,697 股(约 US$7.2M)。 该持仓在 Q3 2026 达到峰值 579,705 股,市值约 US$37.9M。 在 3 次申报中,Invenomic Capital Management LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 579,705 股、市值约 US$37.9M,环比增持 346,670 股。。 持仓曾出现大幅变动:Q3 2026 增持约 149% (随后一个季度股价上涨 27%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 96.70K | $7.16M | 新进 |
| Q2 2026 | 233.03K | $14.92M | 新进 |
| Q3 2026 | 579.71K | $37.90M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GEHC 与 13F 数据
GEHC(GE HEALTHCARE TECHNOLOGIES I)属于医疗保健行业。我们追踪的基金中还有 25 只申报持有 GEHC,申报仓位最大的包括:DODGE & COX (US$3.16B), Dodge & Cox (US$2.42B), Harris 联合投资(Oakmark) (US$981.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GEHC 的基金
- DODGE & COX 48.30M 股 · $3.16B · Q3 2026
- Dodge & Cox 37.86M 股 · $2.42B · Q2 2026
- Harris 联合投资(Oakmark) 15.33M 股 · $981.25M · Q2 2026
- HARRIS ASSOCIATES L P 14.85M 股 · $970.50M · Q3 2026
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 13.77M 股 · $900.14M · Q3 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 13.34M 股 · $872.20M · Q3 2026
- TRIAN FUND MANAGEMENT, L.P. 3.09M 股 · $201.69M · Q3 2026
更多关于 Invenomic Capital Management LP
常见问题
How long has Invenomic Capital Management LP held GEHC?
Invenomic Capital Management LP has disclosed GEHC holdings in 3 of the last 6 reported quarters, going back to Q2 2025.
What is Invenomic Capital Management LP's current position in GEHC?
As of Q3 2026, Invenomic Capital Management LP holds 579.71K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $37.90M, representing 1.87% of its reported portfolio and ranking #14.
Has Invenomic Capital Management LP been buying or selling GEHC?
In the latest 13F filing (Q3 2026), Invenomic Capital Management LP increased its position in GEHC. The position peaked in Q3 2026 at 579.71K shares.
Which other funds hold GEHC?
Other major institutional holders of GEHC include DODGE & COX, Dodge & Cox, Harris 联合投资(Oakmark), among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.